142 related articles for article (PubMed ID: 18623608)
21. Comparing denominator degrees of freedom approximations for the generalized linear mixed model in analyzing binary outcome in small sample cluster-randomized trials.
Li P; Redden DT
BMC Med Res Methodol; 2015 Apr; 15():38. PubMed ID: 25899170
[TBL] [Abstract][Full Text] [Related]
22. Switching cluster membership in cluster randomized control trials: Implications for design and analysis.
Schweig JD; Pane JF; McCaffrey DF
Psychol Methods; 2020 Aug; 25(4):516-534. PubMed ID: 32271041
[TBL] [Abstract][Full Text] [Related]
23. Nested Markov compliance class model in the presence of time-varying noncompliance.
Lin JY; Ten Have TR; Elliott MR
Biometrics; 2009 Jun; 65(2):505-13. PubMed ID: 18759831
[TBL] [Abstract][Full Text] [Related]
24. Estimation of the risk difference under a noncompliance randomized clinical trial with missing outcomes.
Lui KJ
J Biopharm Stat; 2008; 18(2):273-92. PubMed ID: 18327721
[TBL] [Abstract][Full Text] [Related]
25. Statistical power in randomized intervention studies with noncompliance.
Jo B
Psychol Methods; 2002 Jun; 7(2):178-93. PubMed ID: 12090409
[TBL] [Abstract][Full Text] [Related]
26. Intention to treat, per protocol, as treated and instrumental variable estimators given non-compliance and effect heterogeneity.
McNamee R
Stat Med; 2009 Sep; 28(21):2639-52. PubMed ID: 19579227
[TBL] [Abstract][Full Text] [Related]
27. Identification of causal effects using instrumental variables in randomized trials with stochastic compliance.
Scosyrev E
Biom J; 2013 Jan; 55(1):97-113. PubMed ID: 23180483
[TBL] [Abstract][Full Text] [Related]
28. The implications of noncompliance for randomized trials with partial nesting due to group treatment.
Roberts C
Stat Med; 2021 Jan; 40(2):349-368. PubMed ID: 33118193
[TBL] [Abstract][Full Text] [Related]
29. Multiple imputation methods for treatment noncompliance and nonresponse in randomized clinical trials.
Taylor L; Zhou XH
Biometrics; 2009 Mar; 65(1):88-95. PubMed ID: 18397338
[TBL] [Abstract][Full Text] [Related]
30. Identifiability and estimation of causal effects in randomized trials with noncompliance and completely nonignorable missing data.
Chen H; Geng Z; Zhou XH
Biometrics; 2009 Sep; 65(3):675-82. PubMed ID: 18759847
[TBL] [Abstract][Full Text] [Related]
31. Test homogeneity of odds ratio in a randomized clinical trial with noncompliance.
Lui KJ; Chang KC
J Biopharm Stat; 2009 Sep; 19(5):916-32. PubMed ID: 20183452
[TBL] [Abstract][Full Text] [Related]
32. A causal proportional hazards estimator for the effect of treatment actually received in a randomized trial with all-or-nothing compliance.
Loeys T; Goetghebeur E
Biometrics; 2003 Mar; 59(1):100-5. PubMed ID: 12762446
[TBL] [Abstract][Full Text] [Related]
33. Disentangling estimands and the intention-to-treat principle.
Leuchs AK; Brandt A; Zinserling J; Benda N
Pharm Stat; 2017 Jan; 16(1):12-19. PubMed ID: 27910217
[TBL] [Abstract][Full Text] [Related]
34. Sample size estimation for stratified individual and cluster randomized trials with binary outcomes.
Kennedy-Shaffer L; Hughes MD
Stat Med; 2020 May; 39(10):1489-1513. PubMed ID: 32003492
[TBL] [Abstract][Full Text] [Related]
35. Sensitivity of estimands in clinical trials with imperfect compliance.
Chen H; Heitjan DF
Int J Biostat; 2024 May; 20(1):57-67. PubMed ID: 37365674
[TBL] [Abstract][Full Text] [Related]
36. Repairing the efficiency loss due to varying cluster sizes in two-level two-armed randomized trials with heterogeneous clustering.
Candel MJ; Van Breukelen GJ
Stat Med; 2016 May; 35(12):2000-15. PubMed ID: 26756696
[TBL] [Abstract][Full Text] [Related]
37. Deviation from intention to treat analysis in randomised trials and treatment effect estimates: meta-epidemiological study.
Abraha I; Cherubini A; Cozzolino F; De Florio R; Luchetta ML; Rimland JM; Folletti I; Marchesi M; Germani A; Orso M; Eusebi P; Montedori A
BMJ; 2015 May; 350():h2445. PubMed ID: 26016488
[TBL] [Abstract][Full Text] [Related]
38. Cluster randomized trials with a small number of clusters: which analyses should be used?
Leyrat C; Morgan KE; Leurent B; Kahan BC
Int J Epidemiol; 2018 Feb; 47(1):321-331. PubMed ID: 29025158
[TBL] [Abstract][Full Text] [Related]
39. A comparison of methods for estimating the causal effect of a treatment in randomized clinical trials subject to noncompliance.
Little RJ; Long Q; Lin X
Biometrics; 2009 Jun; 65(2):640-9. PubMed ID: 18510650
[TBL] [Abstract][Full Text] [Related]
40. A comparison of confidence interval methods for the intraclass correlation coefficient in community-based cluster randomization trials with a binary outcome.
Braschel MC; Svec I; Darlington GA; Donner A
Clin Trials; 2016 Apr; 13(2):180-7. PubMed ID: 26415500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
